BACKGROUND: NOD2 single nucleotide polymorphisms have been associated with increased risk of ileal Crohn's disease (CD). This exploratory study was conducted to compare ileal mucosal gene expression in CD patients with and without NOD2 risk alleles. METHODS: Ileal samples were prospectively collected from 18 nonsmoking CD patients not treated with anti-TNF-α biologics and 9 nonsmoking control patients without inflammatory bowel disease undergoing initial resection and genotyped for the 3 major NOD2 risk alleles (Arg702Trp, Gly908Arg, Leu1007fs). Microarray analysis was performed in samples from 4 NOD2(R) (at least 1 risk allele) CD patients, 4 NOD2(NR) (no risk alleles) CD patients, and 4 NOD2(NR) controls. Candidate genes selected by significance analysis of microarrays (SAM) were confirmed by quantitative reverse transcriptase polymerase chain reaction (qRT-PCR) assays of all the samples. RESULTS: SAM detected upregulation of 18 genes in affected ileum in NOD2(R) compared to NOD2(NR) CD patients, including genes related to lymphocyte activation. SAM also detected altered ileal gene expression in unaffected NOD2(NR) ileal mucosal CD samples compared to NOD2(NR) control samples. qRT-PCR conducted on all the samples confirmed that increased CD3D expression in affected samples was associated with NOD2(R) status, and that increased MUC1, DUOX2, DMBT1 and decreased C4orf7 expression in unaffected samples was associated with CD, independent of NOD2 status. CONCLUSIONS: The results support the concept that NOD2 risk alleles contribute to impaired regulation of inflammation in the ileum. Furthermore, altered ileal gene expression, independent of NOD2 status, is detected in the unaffected proximal margin of resected ileum from CD patients.
BACKGROUND:NOD2 single nucleotide polymorphisms have been associated with increased risk of ileal Crohn's disease (CD). This exploratory study was conducted to compare ileal mucosal gene expression in CDpatients with and without NOD2 risk alleles. METHODS: Ileal samples were prospectively collected from 18 nonsmoking CDpatients not treated with anti-TNF-α biologics and 9 nonsmoking control patients without inflammatory bowel disease undergoing initial resection and genotyped for the 3 major NOD2 risk alleles (Arg702Trp, Gly908Arg, Leu1007fs). Microarray analysis was performed in samples from 4 NOD2(R) (at least 1 risk allele) CDpatients, 4 NOD2(NR) (no risk alleles) CDpatients, and 4 NOD2(NR) controls. Candidate genes selected by significance analysis of microarrays (SAM) were confirmed by quantitative reverse transcriptase polymerase chain reaction (qRT-PCR) assays of all the samples. RESULTS: SAM detected upregulation of 18 genes in affected ileum in NOD2(R) compared to NOD2(NR) CDpatients, including genes related to lymphocyte activation. SAM also detected altered ileal gene expression in unaffected NOD2(NR) ileal mucosalCD samples compared to NOD2(NR) control samples. qRT-PCR conducted on all the samples confirmed that increased CD3D expression in affected samples was associated with NOD2(R) status, and that increased MUC1, DUOX2, DMBT1 and decreased C4orf7 expression in unaffected samples was associated with CD, independent of NOD2 status. CONCLUSIONS: The results support the concept that NOD2 risk alleles contribute to impaired regulation of inflammation in the ileum. Furthermore, altered ileal gene expression, independent of NOD2 status, is detected in the unaffected proximal margin of resected ileum from CDpatients.
Authors: M Hausmann; T Spöttl; T Andus; G Rothe; W Falk; J Schölmerich; H Herfarth; G Rogler Journal: Clin Exp Immunol Date: 2001-07 Impact factor: 4.330
Authors: Y Ogura; D K Bonen; N Inohara; D L Nicolae; F F Chen; R Ramos; H Britton; T Moran; R Karaliuskas; R H Duerr; J P Achkar; S R Brant; T M Bayless; B S Kirschner; S B Hanauer; G Nuñez; J H Cho Journal: Nature Date: 2001-05-31 Impact factor: 49.962
Authors: Steven R Brant; Michael F Picco; Jean-Paul Achkar; Theodore M Bayless; Sunanda V Kane; Aaron Brzezinski; Franklin J Nouvet; Denise Bonen; Amir Karban; Themistocles Dassopoulos; Reda Karaliukas; Terri H Beaty; Stephen B Hanauer; Richard H Duerr; Judy H Cho Journal: Inflamm Bowel Dis Date: 2003-09 Impact factor: 5.325
Authors: Y Ogura; S Lala; W Xin; E Smith; T A Dowds; F F Chen; E Zimmermann; M Tretiakova; J H Cho; J Hart; J K Greenson; S Keshav; G Nuñez Journal: Gut Date: 2003-11 Impact factor: 23.059
Authors: Floris J Bikker; Antoon J M Ligtenberg; Kamran Nazmi; Enno C I Veerman; Wim van't Hof; Jan G M Bolscher; Annemarie Poustka; Arie V Nieuw Amerongen; Jan Mollenhauer Journal: J Biol Chem Date: 2002-06-05 Impact factor: 5.157
Authors: Aaron J Marshall; Quijiang Du; Kevin E Draves; Yasufumi Shikishima; Kent T HayGlass; Edward A Clark Journal: J Immunol Date: 2002-09-01 Impact factor: 5.422
Authors: Maria T Abreu; Kent D Taylor; Ying-Chao Lin; Tieu Hang; Joanne Gaiennie; Carol J Landers; Eric A Vasiliauskas; Lori Y Kam; Micha Rojany; Konstantinos A Papadakis; Jerome I Rotter; Stephan R Targan; Huiying Yang Journal: Gastroenterology Date: 2002-09 Impact factor: 22.682
Authors: M F Neurath; B Weigmann; S Finotto; J Glickman; E Nieuwenhuis; H Iijima; A Mizoguchi; E Mizoguchi; J Mudter; P R Galle; A Bhan; F Autschbach; B M Sullivan; S J Szabo; L H Glimcher; R S Blumberg Journal: J Exp Med Date: 2002-05-06 Impact factor: 14.307
Authors: Helmut Grasberger; Xavier De Deken; Olga Barca Mayo; Houssam Raad; Mia Weiss; Xiao-Hui Liao; Samuel Refetoff Journal: Mol Endocrinol Date: 2012-02-02
Authors: Ellen Li; Christina M Hamm; Ajay S Gulati; R Balfour Sartor; Hongyan Chen; Xiao Wu; Tianyi Zhang; F James Rohlf; Wei Zhu; Chi Gu; Charles E Robertson; Norman R Pace; Edgar C Boedeker; Noam Harpaz; Jeffrey Yuan; George M Weinstock; Erica Sodergren; Daniel N Frank Journal: PLoS One Date: 2012-06-13 Impact factor: 3.240
Authors: Stefan H Oehlers; Maria Vega Flores; Chris J Hall; Simon Swift; Kathryn E Crosier; Philip S Crosier Journal: Dis Model Mech Date: 2011-07-04 Impact factor: 5.758
Authors: Tianyi Zhang; Robert A DeSimone; Xiangmin Jiao; F James Rohlf; Wei Zhu; Qing Qing Gong; Steven R Hunt; Themistocles Dassopoulos; Rodney D Newberry; Erica Sodergren; George Weinstock; Charles E Robertson; Daniel N Frank; Ellen Li Journal: PLoS One Date: 2012-06-13 Impact factor: 3.240
Authors: Maaike Vancamelbeke; Tim Vanuytsel; Ricard Farré; Sare Verstockt; Marc Ferrante; Gert Van Assche; Paul Rutgeerts; Frans Schuit; Séverine Vermeire; Ingrid Arijs; Isabelle Cleynen Journal: Inflamm Bowel Dis Date: 2017-10 Impact factor: 5.325
Authors: Yonghzong Wu; Smitha Antony; Stephen M Hewitt; Guojian Jiang; Sherry X Yang; Jennifer L Meitzler; Agnes Juhasz; Jiamo Lu; Han Liu; James H Doroshow; Krishnendu Roy Journal: Int J Oncol Date: 2013-02-11 Impact factor: 5.650